Leica LMD7000 Laser Microdissection System

Leica LMD7000 激光显微切割系统

基本信息

项目摘要

DESCRIPTION (provided by applicant): The Histology and Microscopy Core facility at the Ernest Gallo Clinic and Research Center (EGCRC) at the University of California, San Francisco provides shared equipment and training in methods that use microscopy for investigating molecular and structural changes in the brain that underlie drug and alcohol dependence. These questions have been traditionally addressed using immunocytochemistry and in situ hybridization, and for the past decade, with the NIH-developed method of laser capture microdissection (LCM), which offers the possibility of selectively collecting specific cell populations from counterstained histological sections. The original infrared (IR) laser-based PixCell IIe system (Arcturus) was purchased by the EGCRC in 2001. Since then this instrument has allowed our investigators to measure mRNA abundance in subpopulations of invertebrate and mammalian cells by RT-PCR and microarray technology. However, over the last several years, technical drawbacks with this IR laser-based LCM design have become evident. First, it can optimally use only 5-8 micron thick sections and is thus limited to analysis of small amounts of tissue. Second, our PixCell IIe system is manual and cannot outline and then dissect out a brain region using an automated function. Furthermore, to obtain the most effective IR pulses, one must refocus the manual laser before and during tissue collection, which is very time-consuming. In addition, investigating regions of the brain infected with viruses for RNA interference studies has proven very difficult to perform due to the need to collect many thousands of cells from each animal. Therefore, despite a significant need for LCM in our experiments, our current system is extremely inadequate. Recently, LCM vendors have developed systems that use ultraviolet (UV) lasers as a cutting tool and this development has proven to be a major improvement. Since our PixCell IIe is not upgradeable, we now seek to acquire the most up-to-date instrument, an LDM7000 from Leica Microsystems. The requested instrument will be equipped with the highly effective UV cutting laser, automated region collection and other options that will greatly assist in obtaining better samples at reduced cost and time. With the LDM7000 our investigators will be able to continue to perform NIH-funded experiments and avoid the serious limitations imposed by the outdated equipment currently at the EGCRC.
描述(由申请人提供):加州大学旧金山分校欧内斯特·加洛诊所和研究中心(EGCRC)的组织学和显微镜核心设施提供共享设备和方法培训,使用显微镜研究导致药物和酒精依赖的大脑分子和结构变化。这些问题传统上是通过免疫细胞化学和原位杂交来解决的,在过去的十年里,使用NIH开发的激光捕获显微解剖(LCM)方法,提供了从反染色的组织切片中选择性地收集特定细胞群的可能性。最初的基于红外(IR)激光的PixCell IIe系统(Arcturus)于2001年被EGCRC购买。从那时起,这台仪器使我们的研究人员能够通过RT-PCR和微阵列技术测量无脊椎动物和哺乳动物细胞亚群中的mRNA丰度。然而,在过去的几年里,这种基于红外激光的LCM设计的技术缺陷已经变得明显。首先,它最好只使用5-8微米厚的切片,因此仅限于对少量组织的分析。其次,我们的PixCell IIe系统是手动的,不能用自动功能勾勒出大脑区域的轮廓,然后再进行解剖。此外,为了获得最有效的红外脉冲,必须在组织收集之前和过程中重新聚焦手动激光,这非常耗时。此外,为了进行RNA干扰研究,对大脑中感染病毒的区域进行调查被证明是非常困难的,因为需要从每种动物身上收集数千个细胞。因此,尽管在我们的实验中对LCM的需求很大,但我们目前的系统是极其不足的。最近,LCM供应商开发了使用紫外线(UV)激光作为切割工具的系统,这一开发已被证明是一项重大改进。由于我们的PixCell IIe不可升级,我们现在寻求从徕卡微系统公司购买最新的仪器-LDM7000。所要求的仪器将配备高效的紫外线切割激光、自动区域采集和其他选项,这些选项将极大地帮助以更低的成本和时间获得更好的样品。有了LDM7000,我们的研究人员将能够继续进行NIH资助的实验,并避免EGCRC目前过时的设备造成的严重限制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Viktor Kharazia其他文献

Viktor Kharazia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Viktor Kharazia', 18)}}的其他基金

Vector, Transgenic, and Imaging Core
载体、转基因和成像核心
  • 批准号:
    8794381
  • 财政年份:
  • 资助金额:
    $ 22.19万
  • 项目类别:

相似海外基金

Role of glucocorticoid receptor-mediated mRNA decay in alcohol dependence
糖皮质激素受体介导的 mRNA 衰减在酒精依赖中的作用
  • 批准号:
    10811212
  • 财政年份:
    2023
  • 资助金额:
    $ 22.19万
  • 项目类别:
6/11 Astrocyte-specific changes and interventions in alcohol dependence
6/11 星形胶质细胞特异性变化和酒精依赖干预
  • 批准号:
    10591606
  • 财政年份:
    2022
  • 资助金额:
    $ 22.19万
  • 项目类别:
An Investigation of Reward Processing in Co-occurring Alcohol Dependence and Loss of Control Eating
对同时发生的酒精依赖和饮食失控的奖励处理的研究
  • 批准号:
    486597
  • 财政年份:
    2022
  • 资助金额:
    $ 22.19万
  • 项目类别:
    Studentship Programs
Identifying new targets for the treatment of alcohol dependence and relapse: epigenetic analysis of the abstinent brain
确定治疗酒精依赖和复发的新靶点:戒酒大脑的表观遗传学分析
  • 批准号:
    10396660
  • 财政年份:
    2022
  • 资助金额:
    $ 22.19万
  • 项目类别:
Identifying new targets for the treatment of alcohol dependence and relapse: epigenetic analysis of the abstinent brain
确定治疗酒精依赖和复发的新靶点:戒酒大脑的表观遗传学分析
  • 批准号:
    10553449
  • 财政年份:
    2022
  • 资助金额:
    $ 22.19万
  • 项目类别:
6/11 Astrocyte-specific changes and interventions in alcohol dependence
6/11 星形胶质细胞特异性变化和酒精依赖干预
  • 批准号:
    10409263
  • 财政年份:
    2022
  • 资助金额:
    $ 22.19万
  • 项目类别:
Novel GLT-1 activators for the treatment of alcohol dependence: preclinical studies
用于治疗酒精依赖的新型 GLT-1 激活剂:临床前研究
  • 批准号:
    10517529
  • 财政年份:
    2022
  • 资助金额:
    $ 22.19万
  • 项目类别:
Reducing alcohol-seeking behavior in a rat model of alcohol dependence
减少酒精依赖大鼠模型的寻酒行为
  • 批准号:
    10684236
  • 财政年份:
    2022
  • 资助金额:
    $ 22.19万
  • 项目类别:
Opposing Contributions of Oxytocin and Corticotropin-Release Factor to Alcohol Dependence
催产素和促肾上腺皮质激素释放因子对酒精依赖的相反作用
  • 批准号:
    10451814
  • 财政年份:
    2021
  • 资助金额:
    $ 22.19万
  • 项目类别:
Opposing Contributions of Oxytocin and Corticotropin-Release Factor to Alcohol Dependence
催产素和促肾上腺皮质激素释放因子对酒精依赖的相反作用
  • 批准号:
    10655413
  • 财政年份:
    2021
  • 资助金额:
    $ 22.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了